LongeVC mulls 2023 fundraise for second fund
Latvian biotech-focused sponsor LongeVC could hit the fundraising trail as early as next year as it gears up for its second fund, Managing Partner and co-founder Sergey Jakimov told Unquote.
More on Fundraising
DBAG to target EUR 1.3bn-EUR 1.5bn for new buyout fund next year
German GP’s new vehicle will be slightly larger than its predecessor, which is set to complete deployment in two years
Alcedo heads for June final close for Fund V
Italian GP has received EUR 230m in commitments to date for Fund V against a EUR 250m hard-cap
Eurazeo heads for EUR 1bn H1 2022 close for PME IV
GP also said in its Q1 2022 results that it has EUR 4.7bn in dry powder across its strategies
EMZ in final stretch of EUR 1.2bn EMZ 10 fundraise
EMZ 10 held a first close in excess of EUR 800m earlier in May and continues to seek new LPs
Latest News
Verdane scores 5x MOIC in partial exit of Inriver to THL
Majority investment from THL Partners sees Verdane retain a minority stake in the Swedish company
CVC to buy sports nutrition specialist The Quality Group
GP to acquire majority stake via Fund VIII; German group’s founders to reinvest in the deal
DBAG to target EUR 1.3bn-EUR 1.5bn for new buyout fund next year
German GP’s new vehicle will be slightly larger than its predecessor, which is set to complete deployment in two years
Alcedo heads for June final close for Fund V
Italian GP has received EUR 230m in commitments to date for Fund V against a EUR 250m hard-cap